Keda is expected to have a net profit of 2.15 billion, and the net profit of the parent company of E

Mondo Finance Updated on 2024-02-24

On the evening of January 26, Keda Manufacturing released the "2023 Annual Performance Forecast", which is expected to achieve a net profit attributable to shareholders of listed companies in 2023 of 21about 500 million yuan, compared with the same period last year, it is expected to decrease by 210.1 billion yuan, a year-on-year decrease of about 4942%。

The main reason for the change in performance is that in recent years, with the fluctuation of the lithium carbonate market and the release of lithium carbonate production capacity of Qinghai Salt Lake Lanke Lithium Co., Ltd., a shareholding company of the company, the operation of Lanke Lithium has a great impact on the company's performance. In 2022, its impact on the company's profit accounted for more than 80% of the company's net profit attributable to shareholders of listed companies. During the reporting period, the production and sales volume of Lanke Lithium achieved good year-on-year growth, and at the same time, the lithium carbonate market terminal ** continued from about 500,000 tons at the beginning of the reporting period to less than 100,000 tons at the end of the reporting period, with the violent fluctuation of lithium carbonate**, the performance of Lanke Lithium decreased by about 62% compared with the same period last year, resulting in a decrease of about 2.1 billion yuan on the company's net profit attributable to shareholders of listed companies compared with the same period last year.

In addition, due to the global economic slowdown and the impact of the domestic real estate market, the company's building materials and machinery business fluctuated slightly. In order to actively respond to market changes, the company has continued to increase the market layout of ceramic machinery overseas and accessories and consumables, the development of the field of generalization of ceramic machinery in 2023, and promote the project construction and brand operation of overseas building materials business to help the sustainable development of the company's business.

Image display **Irrelevant On the evening of January 25, Tianan New Materials released the 2023 annual performance pre-profit announcementIt is expected to achieve net profit attributable to shareholders of listed companies in 20231100 million yuan-1300 million yuanAchieve turnaround; It is estimated that the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses will be 66 million yuan to 86 million yuan.

Tianan New Materials specializes in the research and development, design, production and sales of polymer composite finishing materials and architectural ceramics, and actively broadens the development direction of the enterprise and enriches the company's high-quality product supply through capital mergers and acquisitions and technological innovation.

Since the acquisition of Eagle Ceramics of Tianan New Material Holdings, relying on the foundation of the three major building ceramics brands of Eagle Brand, Eagle Brand 2086 and Huapeng, it has established two major complete brands of Eagle Life and Eagle Brand Renovation Home. In 2023, Eagle Ceramics will build new central warehouses in Kunming, Guizhou, Changsha and other cities, and Huapeng Ceramics will establish a Beijing-Tianjin-Hebei operation center, and the national layout of the marketing center will be accelerated, realizing the rapid sinking of channels, expanding sales scale, and effectively increasing market share. During the reporting period, the company's orders for architectural ceramics products increased, and the operating income increased by about 21% year-on-year.

Image display **Irrelevant On January 26, Shanghai Yuexin Health Group Co., Ltd. *** referred to as "Yuexin Health") issued a performance forecast, saying that it is expected that the net profit attributable to shareholders of listed companies in 2023 will be 40 million yuan and 60 million yuan, compared with a loss of 2 in the same period last year7.8 billion yuan, a year-on-year turnaround; The net loss after deducting non-recurring gains and losses is expected to be 1$2.5 billion 10.5 billion yuan, a loss of 2 in the same period last year$1.9 billion; It is expected that the operating income will be 1.2 billion yuan and 1.3 billion yuan, compared with about 11 in the same period last year6.3 billion yuan, a year-on-year increase of 321%-11.82%。

In terms of the reasons for the change in performance, Yuexin Health saidIn 2023, the sales revenue of ceramic tiles will increase by about 11% over the same period of the previous yearThe revenue of the big health segment increased by about 6% over the same period last year4%。The company expects the impairment loss of various assets in the reporting period to be 1200 million yuan, 1 over the same period last year900 million yuan, reducing losses of about 70 million yuan; The asset disposal loss in the reporting period was about 4.6 million yuan, and the asset disposal loss due to the termination of the negative ion health materials business and the transformation of the Jiangxi production line in the same period last year was about 65 million yuan, a year-on-year decrease of about 61 million yuan.

In 2023, Yuexin Health's net profit attributable to shareholders of listed companies will be about 40 million yuan to 60 million yuan, of which the non-recurring profit and loss profit will be about 16.5 billion yuan, mainly due to the transfer of part of the equity of Shanghai Yuexin Health Technology Development, a wholly-owned subsidiary of Yuexin Health, during the reporting period, and the income related to the equity transfer was about 16.6 billion yuan (before tax), including the corresponding comprehensive income formed when self-used real estate is converted into investment real estate, which lost control after the transfer of equity, and was recognized as a current income of 90.74 million yuan. In 2022, the company terminated the negative ion health materials business and disposed of non-performing assets, and will no longer incur operating losses related to these businesses in 2023.

End of text).

Image display **Unrelated

Related Pages